WeVote
Log In

Bill

Bill

SB 166

An Act establishing the Alaska mental health and psychedelic medicine task force; and providing for an effective date.

33rd Legislature (2023-2024) Introduced by Forrest Dunbar and 2 co-sponsors

Alaska establishes mental health task force to study psychedelic medicine research and recommend treatment policy options to legislators.

(S) COSPONSOR(S): TOBIN
#appointments #boards&commissions #business #drugs #legislature #medicalcare #mentalhealth #physicians
0

WeVote — Public opinion

No community votes yet. Be the first to weigh in from the Vote tab.

Bill text & amendments

SB166 Research - NIH Abstract 9.8.2023 SB 166 Testimony Received by 2.20.24 SB166 Draft Proposed CS ver Y CSSB 166 ver P Sponsor Statement 2.20.2024 SB166 Summary of Changes ver S to CS ver Y 02.16.24 SB 166 Research - Filter 2.15.24 SB166 Research - VETS Press Release Ibogaine 1.5.2024 SB166 Research - MAPS Press Release 12.13.2023 SB166 Public Testimony Received by by sponsor 02.05.24 SB 166 Sectional Analysis 2.20.2024 SB 166 Research - VETS Press Release Ibogaine 1.5.2024 SB166 Sectional Analysis 1.25.2024 HB 228 T.A vs SB 166 N Summary of Differences 5.3.2024 SB166 Fiscal Note-DCCED-COMM 02.16.24 SB166 Public Testimony-APRN Alliance 02.01.24 CSSB 166 ver P Summary of Changes 2.20.24 SB166 Public Testimony-Tammi Lubitsh-White 02.15.24 SB 166 Research - NIH Abstract 9.8.2023 SB 166 Letter of Support - APRN Alliance 2.22.24 SB166 Fiscal Note-DCCED-COMM 02.01.24 CSSB 166 (L&C) ver P SB 166 Amendment 2.26.2024 SB166 Sponsor Statement 1.29.2024 SB166 Public Testimony-Brooke Lavender 02.05.24 SB166 ver S